Zhang W, Deng P, Kong T, Zhang B, et al. Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2). Lung Cancer 2022;173:43-48.
PMID: 36116169